Clinical Trial

A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults

Name: A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults — clinical trial record (NCT07226362)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

A Phase 1 clinical trial to evaluate the pharmacokinetics, relative bioavailability, safety and tolerability of DHE inhalation powder delivered by dry powder inhaler, DHE IV, and DHE nasal spray.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-07.

Trial Details

NCT Number	NCT07226362
Lead Sponsor	Aspeya Switzerland SA
Conditions	Safety, and Tolerability
Enrollment	44 participants
Start Date	2025-06-09
Primary Completion	2025-10-02 (estimated)
Study Completion	2025-10-02 (estimated)
Updated on ClinicalTrials.gov	2026-03-19